Trials / Completed
CompletedNCT00370864
Study of a Pandemic Influenza Vaccine in Children
Phase II Study of a Pandemic Influenza Vaccine in Children
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- Seqirus · Industry
- Sex
- All
- Age
- 6 Months – 8 Years
- Healthy volunteers
- Accepted
Summary
The World Health Organisation has warned that an influenza pandemic is inevitable. The avian influenza strain H5N1 is one of the leading candidates to cause the next influenza pandemic. Children are likely to be a special target group for vaccination; therefore, this study will test the safety and immunogenicity of an H5N1 pandemic influenza vaccine in healthy children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | H5N1 pandemic influenza vaccine |
Timeline
- Start date
- 2006-09-01
- Completion
- 2007-07-01
- First posted
- 2006-09-01
- Last updated
- 2016-07-19
Locations
2 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00370864. Inclusion in this directory is not an endorsement.